(Q41552526)

3 October 2017

1 reference

title

Animal models of anxiety: an ethological perspective (English)

1 reference

3 October 2017

R J Rodgers

1

1 reference

3 October 2017

B J Cao

series ordinal

2

1 reference

3 October 2017

A Dalvi

series ordinal

3

1 reference

3 October 2017

A Holmes

series ordinal

4

1 reference

3 October 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

Brazilian Journal of Medical and Biological Research

3 October 2017

published in

1 reference

3 October 2017

volume

30

1 reference

3 October 2017

issue

3

1 reference

3 October 2017

page(s)

289-304

1 reference

Ethologically-based animal models of anxiety disorders

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Guidelines for the rational use of benzodiazepines. When and what to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Neurochemical and cognitive aspects of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Emotion: clues from the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

The characterization and modelling of antipredator defensive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

The infant rat separation paradigm: a novel test for novel anxiolytics

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Antipredator defensive behaviors in a visible burrow system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

The relation between fear induced by novel stimulation and exploratory drive

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

The use of a plus-maze to measure anxiety in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Daily rhythms in spontaneous and diazepam-induced anxiolysis in Syrian hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Use of the elevated plus maze in the search for novel anxiolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Lasting effects on rodent anxiety of a single exposure to a cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

On aims and methods of Ethology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Anxiogenic stimuli in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

The influence of open arm ledges and maze experience in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Differences in fear motivated behaviors among inbred mouse strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Acute non-opioid analgesia in defeated male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Benzodiazepine ligands, nociception and 'defeat' analgesia in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Blockade of non-opioid analgesia in intruder mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Attenuation of defensive analgesia in male mice by 5-HT3 receptor antagonists, ICS 205-930, MDL 72222, MDL 73147EF and MDL 72699

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

GABAergic influences on plus-maze behaviour in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Anxiety, defence and the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Neurosteroids and GABAA receptor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Serotonin receptors and animal models of aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

5-HT1A receptor agonists: recent developments and controversial issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

The pharmacology of human anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Actions of sulpiride and tiapride in a simple model of anxiety in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

Benefits of ethological analysis of behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X1997000300002

10.1590/S0100-879X1997000300002

21 January 2018

Identifiers

DOI

1 reference

3 October 2017

1 reference